Key Drivers
- Thin Margins
- Weakening Cash Flow
- Adequate Liquidity
AIAI Summary
PRVA is a hold/watch-for-proof story: strong growth and activist pressure could unlock a rerating, but its ~1% net margin, weak recent free-cash-flow conversion, and rich valuation require evidence that receivables normalize and incremental revenue produces durable margin expansion before buying aggressively.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Thin Margins
- •Weakening Cash Flow
- •Adequate Liquidity
PRVA has adequate liquidity and low debt, but thin profitability, sharply weaker quarterly free cash flow, and still-high valuation multiples warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support test
- •Weak momentum
PRVA remains bearish after falling 6.4% over the last month to $19.85, with downside risk increasing if support breaks and recovery requiring a move above $20.42.
Steady 6.4% decline over the last month
Sentiment & News
Key News Insights:
- •BlackRock lead
- •New positions
- •Broad interest
Major institutional investors, led by BlackRock's $550.7M stake, disclosed new Privia Health positions, signaling strong institutional interest.
The sizable institutional buying could support positive sentiment for PRVA shares
Similar Companies in Healthcare
Other companies in the same sector with AI ratings